ZIRCAIX
LIVE

Serial Number

79375152

Owner

Telix Pharmaceuticals Limited

Filing Date

Jun 29, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ZIRCAIX Trademark

Serial Number: 79375152 • Registration: 7435713

ZIRCAIX is a trademark filed by Telix Pharmaceuticals Limited on June 29, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

June 29, 2023

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing, monitoring and treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing, monitoring and treatment of cancer

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 10, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 25, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 25, 2024 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 8, 2024 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Apr 23, 2024 GPNX
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2024 OPNS
NOTICE OF PUBLICATION
Apr 3, 2024 NPUB
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2024 CNSA
ASSIGNED TO EXAMINER
Mar 14, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 15, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 8, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 27, 2023 REPR